Tech News St. Vincent & Grenadines: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News St. Vincent & Grenadines.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 16, 2026

January 16, 2026

DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing

GlobeNewswire

January 16, 2026

DBV Technologies annonce avoir reçu un produit brut de 166,7 millions d'euros suite à l'exercice intégral des Bons de Souscription (BS) issus des ABSAs et des BS issus des PFW-BS-PFW émis dans le cadre de son financement de mars 2025

GlobeNewswire

January 16, 2026

VERSES® Restructures to Focus on Core Target Market

GlobeNewswire

January 16, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

January 16, 2026

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

January 16, 2026

Aduro Clean Technologies gibt Ergebnisse für das zweite Quartal des Geschäftsjahres 2026 bekannt und informiert über den aktuellen Stand des Geschäfts

GlobeNewswire

January 16, 2026

Aduro Clean Technologies présente les résultats financiers de son deuxième trimestre 2026 et fait le point sur ses activités

GlobeNewswire

January 16, 2026

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

January 16, 2026

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency

GlobeNewswire

January 16, 2026

Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

January 16, 2026

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

January 16, 2026

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

January 16, 2026

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

GlobeNewswire

January 16, 2026

CORRECTION - American Rebel Holdings, Inc. (NASDAQ: AREB) and American Rebel Light Beer Charge Into 2026: Virginia’s Lawrence Distributing Company Added as Distribution Growth Accelerates and Retail Rollouts Expand

GlobeNewswire

January 16, 2026

Metabo Drops Investigated (REPORT 2026) in the Frame of General Debates in Metabolic Health, Supplement Form, and Informed Consumer Analysis

GlobeNewswire

January 16, 2026

Michael Harrington Highlights QuantCore 5.0 Deployment as VMA Community Updates AI Analysis Infrastructure

GlobeNewswire

January 16, 2026

Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares

GlobeNewswire

January 16, 2026

First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study

GlobeNewswire

$Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)$

January 16, 2026

Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

GlobeNewswire

January 16, 2026

Helix Alpha Brings Execution-Driven Edge with Appointment of Brian Ferdinand as Strategic Advisor

GlobeNewswire